BRIEF-Ionis to independently advance inotersen and IONIS-FB-L Rx By: Reuters: Company News August 11, 2017 at 07:09 AM EDT * Ionis Pharmaceuticals Inc - Has retained all rights to inotersen and IONIS-FB-L(Rx). Read More >> Related Stocks: Gsk Plc ADR Ionis Pharmaceuticals